These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38714204)

  • 21. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth.
    Amabebe E; Chapman DR; Stern VL; Stafford G; Anumba DOC
    J Reprod Immunol; 2018 Apr; 126():1-10. PubMed ID: 29367099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Independent Association of a Short Cervix, Positive Fetal Fibronectin, Amniotic Fluid Sludge, and Cervical Funneling with Spontaneous Preterm Birth in Twin Pregnancies.
    Spiegelman J; Booker W; Gupta S; Lam-Rochlin J; Rebarber A; Saltzman DH; Monteagudo A; Fox NS
    Am J Perinatol; 2016 Oct; 33(12):1159-64. PubMed ID: 27434692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasa Previa and the Role of Fetal Fibronectin and Cervical Length Surveillance: A Review.
    Oladipo AF; Voity K; Murphy K; Alvarez M; Alvarez-Perez J
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial.
    Ness A; Visintine J; Ricci E; Berghella V
    Am J Obstet Gynecol; 2007 Oct; 197(4):426.e1-7. PubMed ID: 17904989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
    van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
    Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
    Hermans FJR; Bruijn MMC; Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HCJ; Bloemenkamp KWM; Bax CJ; Cornette JMJ; Nij Bijvanck BWA; Franssen MTM; Vandenbussche FPHA; Kok M; Grobman WA; Van Der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ; Schuit E; Van Baaren GJ
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):715-721. PubMed ID: 25845495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transvaginal ultrasonography to predict preterm birth in women with bicornuate or didelphus uterus.
    Crane J; Scott H; Stewart A; Chandra S; Whittle W; Hutchens D
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1960-4. PubMed ID: 22443490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit?
    Lifshitz SJ; Razavi A; Bibbo C; Rebarber A; Roman AS; Saltzman DH; Fox NS
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):566-70. PubMed ID: 23919826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study.
    Holzer I; Koch-Trappel M; Leitich H; Meyer EL; Farr A; Helmer H
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():22-25. PubMed ID: 32058186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the impact of fetal fibronectin test implementation on hospital admissions for preterm labour in Ontario: a multiple baseline time-series design.
    Fell DB; Sprague AE; Grimshaw JM; Yasseen AS; Coyle D; Dunn SI; Perkins SL; Peterson WE; Johnson M; Bunting PS; Walker MC
    BJOG; 2014 Mar; 121(4):438-46. PubMed ID: 24289187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the ability of cervical length and fetal fibronectin measurement to predict preterm delivery in asymptomatic women with risk factors.
    Zhou MX; Zhou J; Bao Y; Chen YQ; Cai C
    J Matern Fetal Neonatal Med; 2015 Jan; 28(2):153-7. PubMed ID: 24678648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor.
    Nikolova T; Bayev O; Nikolova N; Di Renzo GC
    J Perinat Med; 2015 Jul; 43(4):395-402. PubMed ID: 25562603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women.
    Kuhrt K; Smout E; Hezelgrave N; Seed PT; Carter J; Shennan AH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):104-9. PubMed ID: 25846437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ultrasound-indicated cerclage in twin pregnancies.
    Roman A; Rochelson B; Fox NS; Hoffman M; Berghella V; Patel V; Calluzzo I; Saccone G; Fleischer A
    Am J Obstet Gynecol; 2015 Jun; 212(6):788.e1-6. PubMed ID: 25637840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for assessing pre-induction cervical ripening.
    Ezebialu IU; Eke AC; Eleje GU; Nwachukwu CE
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010762. PubMed ID: 26068943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical elastography in predicting spontaneous preterm birth in singleton pregnancy with a short cervix receiving progesterone treatment at 18 to 24 weeks' gestation.
    He B; Zhou Y; Cao L; Yao B; Gao H; Zhang H
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2347954. PubMed ID: 38714523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.